Stamford, CT -- (SBWIRE) -- 10/05/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: National Bank of Greece (ADR) (NYSE:NBG), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Geron Corporation (NASDAQ:GERN), TherapeuticsMD Inc (NYSEMKT:TXMD)
National Bank of Greece (ADR) (NYSE:NBG) started its trading session with the price of $4.40 and closed at $4.59by scoring +9.55%.
Previous 5 days graph demonstrated an optimistic move of +9.81%. NBG’s quarterly performance remained in the green with the percentage of +57.73, while its year to date performance showed that the stock advanced overall -74.36%.
NBG’s stocks traded with total volume of 6.63 million shares, while the average trading volume remained 2.41 million shares. National Bank of Greece S.A., together with its subsidiaries, provides diversified financial services primarily in Greece. The company involves in retail and commercial banking, global investment management, investment banking, insurance, investment activities, and securities trading operations.
For How Long NBG’s Gloss will Attract Investors? Find out via this report
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) ended its day with the gain of +5.07% and closed at the price of $4.56 after opening at $4.36. Stock traded during its last trading session with the total volume of 1.73 million shares, as compared to its average volume of 4.03 million shares.
AVNR’s total market capitalization is $663.34 million, along with 145.47 million shares outstanding. The 52 week range of the stock remained $2.07 - $6.00, while its day's lowest price was $4.36 and its hit its day's highest price at $4.60. The beta of AVNR stands at 1.65. Avanir Pharmaceuticals, Inc., together with its subsidiaries, engages in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States. It primarily offers NUEDEXTA, a proprietary combination of dextromethorphan and low-dose quinidine for the treatment of pseudobulbar affect; and Docosanol 10% cream, an over-the-counter product for the treatment of cold sores.
For How Long AVNR will fight for Profitability? Read This Trend Analysis report
Geron Corporation (NASDAQ:GERN) stock is at $3.35, up +5.68 percent from its previous close of $3.17. The stock opened the session at $3.16 and touched its highest price point at $3.38. GERN stock’s lowest price point for the session stood at $3.15.
Stocks graphical chart shows a bullish trend during its last one month’s trading session. It remained positive +126.35% during the previous three months trade.
Its total trading volume is 1.72 million shares for the day, in comparison to its average trading volume of 1.97 million shares. Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California.
Will GERN Continue To Move Higher? Find Out Here
TherapeuticsMD Inc (NYSEMKT:TXMD) stock is at $3.42, up +8.92 percent from its previous close of $3.42. Its today’s volume is 1.70 million shares, in comparison to its average trading volume of 292,941 shares. The stock opened the session at $3.13 and touched its highest price point at $3.80.
TXMD’s lowest price point for the session stood at $3.10 and its 52 week price range stood at $1.25 - $3.80. The company has a total of 144.96 million outstanding shares and its total market capitalization is $495.77 million. Its beta value stands at 3.60 times and earnings per share was -$0.21. TherapeuticsMD, Inc. promotes, distributes and sells certain products developed and sold by Spectrum Health Network, Inc. (Spectrum) relative to its digital media network.
Why Should Investors Buy TXMD After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks:
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)